EUVIMEDEUVIMED entdecken
Crossref

Paraneoplastic autoimmune hypophysitis: a novel form of paraneoplastic endocrine syndrome

Yutaka Takahashi

Endocrine Journal · 2023 · 70 (6) · 559-565

DOI: 10.1507/endocrj.ej23-0050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Journal, 2023. Verfasst von Yutaka Takahashi. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, Nara Medical University, Kashihara 634-8522, Japan. Hauptthemen laut MEDLINE: Autoimmune Hypophysitis, Paraneoplastic Endocrine Syndromes, Hypophysitis, Paraneoplastic Syndromes. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paraneoplastic syndromes are defined by symptoms or signs resulting from damage to organs or tissues that are remote from the site of malignant neoplasms or its metastasis. They are due to tumor secretion of functional hormones or peptides or are related to immune cross-reactivity with the host tissue. In particular, paraneoplastic endocrine syndromes are mainly caused by ectopic hormone production by the tumor such as PTHrP in humoral hypercalcemia in malignancy and ACTH in ectopic ACTH syndrome. Recently, it has been reported that a specific form of hypophysitis is caused as an immune-mediated paraneoplastic syndrome; paraneoplastic autoimmune hypophysitis, in which an ectopic pituitary antigen expression in the tumor evoked autoimmunity against pituitary-specific antigens, resulting in hypophysitis and exhibiting the injury of specific anterior pituitary cells by cytotoxic T cells. This novel clinical entity, paraneoplastic autoimmune hypophysitis consists of several conditions such as anti-PIT-1 hypophysitis and a part of isolated ACTH deficiency and immune checkpoint inhibitor-related hypophysitis with common mechanisms. These conditions can explain at least in part, the underlying mechanisms of acquired specific pituitary hormone deficiencies. In addition, it is important to apply a comprehensive discipline of onco-immuno-endocrinology to understand the pathophysiology and this approach; the expansion and application of immune-mediated paraneoplastic syndrome to endocrine diseases may give a new clue to understand pathophysiology of the autoimmunity against endocrine organs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune HypophysitisParaneoplastic Endocrine SyndromesHypophysitisParaneoplastic SyndromesNeoplasmsHumansAutoantibodiesAdrenocorticotropic Hormone

Stichwörter der Autor:innen

Anti-PIT-1 hypophysitisHypophysitisImmune checkpoint inhibitor-related hypophysitisParaneoplastic autoimmune hypophysitisParaneoplastic syndrome

Substanzen

AutoantibodiesAdrenocorticotropic Hormone

Autor:innen und Institutionen

  • Department of Diabetes and Endocrinology, Nara Medical University, Kashihara 634-8522, Japan.

Zitieren

APA

Takahashi, Y. (2023). Paraneoplastic autoimmune hypophysitis: a novel form of paraneoplastic endocrine syndrome. Endocrine Journal, 70(6), 559-565. https://doi.org/10.1507/endocrj.ej23-0050

Vancouver

Takahashi Y. Paraneoplastic autoimmune hypophysitis: a novel form of paraneoplastic endocrine syndrome. Endocrine Journal. 2023;70(6):559-565. doi:10.1507/endocrj.ej23-0050

BibTeX
@article{Takahashi2023,
  author = {Takahashi, Yutaka},
  title = {Paraneoplastic autoimmune hypophysitis: a novel form of paraneoplastic endocrine syndrome},
  journal = {Endocrine Journal},
  year = {2023},
  volume = {70},
  number = {6},
  pages = {559--565},
  doi = {10.1507/endocrj.ej23-0050}
}
Kostenlos starten →